KYVERNA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.74 USD | +5.13% |
|
-4.91% | 0.00% |
| May. 14 | Kyverna Therapeutics Q1 Loss Narrows | MT |
| May. 14 | Kyverna Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Other Biotechnology & Medical Research | +5.13% | -4.91% | - | - | - | 592M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- KYTX Stock
- Charts Kyverna Therapeutics, Inc.
- Comparison Chart
